Medovex Corporation to Present at the 9th Annual LD Micro Main Event

LOS ANGELES, CA / ACCESSWIRE / November 15, 2016 / Medovex Corporation (Nasdaq: MDVX), a developer of medical technology products, today announced that it will be presenting at the 9th annual LD Micro Main Event on Wednesday, December 7 at 3:30 PM PST / 6:30 PM EST. Medovex’s CEO Jarrett Gorlin, and its President Patrick Kullmann, will be presenting, as well as meeting with investors.

The LD Micro Main Event is the largest independent conference for small/microcap companies and will feature 240 presenting names.

A webcast of the presentation will be available at the investor relations section of the Company’s website at www.medovex.com

View Medovex’s profile here: http://www.ldmicro.com/profile/MDVX

News Compliments of Accesswire

About Medovex

Medovex was formed to acquire and develop a diversified portfolio of potentially ground breaking medical technology products. Criteria for selection include those products with potential for significant improvement in the quality of patient care combined with cost effectiveness. The Company’s first pipeline product, the DenerveX device, is intended to provide long lasting relief from pain associated with facet joint syndrome at significantly less cost than currently available options.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com/events for more information.

Contact:

Name: Jason Assad
Phone: 678-570-6791
Email: Jassad@medovex.com

SOURCE: Medovex via LD Micro

ReleaseID: 448830